Volume : 08, Issue : 06, June – 2021
Title:
31.TO ENHANCE THE META ANALYSIS STUDY ON SACCHAROMYCES BOULARDII’S EFFICACY IN REDUCING ANTIMICROBIAL DIARRHEA IN CHILDREN AND ADULTS
Authors :
Saman Sabir
Abstract :
Background: Antibiotic-associated diarrhea is a major side effect of antibiotic therapy, although it might be avoided by taking probiotics.
Purpose: To enhance our meta-analysis on Saccharomyces boulardii’s effectiveness in preventing antimicrobial diarrhea in kids and adults.
Methods: Until May 2020, the Cochrane Library, MEDLINE, and EMBASE libraries were screened for randomized clinical trials despite language restrictions; additional references were gathered from relevant literature. Our current research was conducted at Services Hospital, Lahore from March 2020 to February 2021. The Grading of References, Valuation, Progress, and Appraisal criteria were used to evaluate the strength of the data.
Results: This revised systematic review included twenty-one randomized controlled trials with a total of 476 individuals, 19 of which have been new research. Antibiotic treatment, compared with placebo or no therapy, decreased the incidence of antimicrobial diarrhea in patients taking antibiotics from 16.9% to 9.7% (risk ratio, RR: 0.48; 96 percent CI: 0.35-0.58, number needed) (as assessed by Study Investigators). Boulardii decreased risk from 21.6 percent to 6.5 percent in children (6 randomized controlled experiments, n=1654, RR: 0.45, 96 percent CI: 0.4-0.7) and from 16.5 percent to 7.3 percent in adults (16 randomized clinical trials, n=3115, RR: 0.48, 96 percent CI: 0.39-0.65). In contrast, S. boulardii decreased the incidence of Clostridium difficile-related diarrhea, except in children (2 randomized controlled trials). Adults (5 randomized controlled studies, n = 1431, RR: 0.9, 96 percent CI: 0.48-1.35) and children (2 randomized control trials, n = 578, RR: 0.26; 96 percent CI: 0.09-0.74) were not affected.
Conclusion: S. boulardii is helpful in reducing the chances of antimicrobial diarrhea in both kids and adults, according to the same meta-analysis.
Keywords: Meta-Analysis Study, Saccharomyces Boulardii’s Efficacy, Antimicrobial Diarrhea, Children Young Adults.
Cite This Article:
Please cite this article in press Saman Sabir., To Enhance The Meta Analysis Study On Saccharomyces Boulardii’s Efficacy In Reducing Antimicrobial Diarrhea In Children And Adults.., Indo Am. J. P. Sci, 2021; 08(06).
Number of Downloads : 10
References:
1. Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2019; 47(1): 43- 50.
2. Turck D, Bernet JP, Marx J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr. 2018; 37(1): 22- 26.
3. Bartlett JG, Gerding DN. Clinical Recognition and diagnosis of Clostridium difficileinfection. Clin Infect Dis. 2018; 46: S12- S18.
4. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines forClostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66(7): e1- e48.
5. Vaughn BP, Lamont JT. Clostridium difficile infection and pseudomembranous colitis. In: MB Wallace, BA Aqel, KD Lindor, KR Devault, eds. Practical Gastroenterology and Hepatology Board Review Toolkit. 2th ed. Chichester, West Sussex; Hoboken, NJ: John Wiley & Sons; 2016: 328- 332.
6. Lawley TD, Clare S, Walker AW, et al. Antibiotic treatment of Clostridium difficilecarrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun. 2019; 77(9): 3661-3669.
7. Kamada N, Chen GY, Inohara N, et al. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2017; 14(7): 685- 690.
8. Sullivan A, Nord CE. Probiotics in human infections. J Antimicrob Chemother.2002; 50(5): 625- 627.
9. Guarino A, Guandalini S, Lo Vecchio A. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2016; 49(Suppl)): S37- S45.
10. Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K+ CL1285® in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study. Arch Med Sci. 2018; 6(1): 56- 64.